Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-05T16:28:53.545Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory

Published online by Cambridge University Press:  19 April 2013

A. Cubillo ,
A. B. Smith ,
N. Barrett ,
V. Giampietro ,
M. Brammer ,
A. Simmons  and
K. Rubia
A. Cubillo
Affiliation:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, King's College London, London, UK
A. B. Smith
Affiliation:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, King's College London, London, UK
N. Barrett
Affiliation:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, King's College London, London, UK
V. Giampietro
Affiliation:
Department of Neuroimaging, Institute of Psychiatry, King's College London, London, UK
M. Brammer
Affiliation:
Department of Neuroimaging, Institute of Psychiatry, King's College London, London, UK
A. Simmons
Affiliation:
Department of Neuroimaging, Institute of Psychiatry, King's College London, London, UK Centre for Neurodegeneration Research, Institute of Psychiatry, King's College London, London, UK NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Trust and Institute of Psychiatry, King's College London, London, UK
K. Rubia*
Affiliation:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, King's College London, London, UK
*
*Address for correspondence: K. Rubia, Ph.D., Department of Child and Adolescent Psychiatry/SGDP, P046, Institute of Psychiatry, 16 De Crespigny Park, London SE5 8AF, UK. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The catecholamine reuptake inhibitors methylphenidate (MPH) and atomoxetine (ATX) are the most common treatments for attention deficit hyperactivity disorder (ADHD). This study compares the neurofunctional modulation and normalization effects of acute doses of MPH and ATX within medication-naive ADHD boys during working memory (WM).

Method

A total of 20 medication-naive ADHD boys underwent functional magnetic resonance imaging during a parametric WM n-back task three times, under a single clinical dose of either MPH, ATX or placebo in a randomized, double-blind, placebo-controlled, cross-over design. To test for normalization effects, brain activations in ADHD under each drug condition were compared with that of 20 age-matched healthy control boys.

Results

Relative to healthy boys, ADHD boys under placebo showed impaired performance only under high WM load together with significant underactivation in the bilateral dorsolateral prefrontal cortex (DLPFC). Both drugs normalized the performance deficits relative to controls. ATX significantly enhanced right DLPFC activation relative to MPH within patients, and significantly normalized its underactivation relative to controls. MPH, by contrast, both relative to placebo and ATX, as well as relative to controls, upregulated the left inferior frontal cortex (IFC), but only during 2-back. Both drugs enhanced fronto-temporo-striatal activation in ADHD relative to control boys and deactivated the default-mode network, which were negatively associated with the reduced DLPFC activation and performance deficits, suggesting compensation effects.

Conclusions

The study shows both shared and drug-specific effects. ATX upregulated and normalized right DLPFC underactivation, while MPH upregulated left IFC activation, suggesting drug-specific laterality effects on prefrontal regions mediating WM.

Keywords

Atomoxetineattention deficit hyperactivity disorderfunctional magnetic resonance imagingmethylphenidaten-backworking memory
Type
Original Articles
Information
Psychological Medicine , Volume 44 , Issue 3 , February 2014 , pp. 633 - 646
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

†

These authors contributed equally as joint first authors.

References

APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. American Psychiatric Association: Washington, DC.Google Scholar
Baddeley, A (1996). The fractionation of working memory. Proceedings of the National Academy of Sciences USA 93, 13468–13472.CrossRefGoogle ScholarPubMed
Brain Image Analysis Unit (2011). XBAM (http://www.brainmap.co.uk). Accessed 24 April 2012.Google Scholar
Brammer, MJ, Bullmore, ET, Simmons, A, Williams, SC, Grasby, PM, Howard, RJ, Woodruff, PW, Rabe-Hesketh, S (1997). Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magnetic Resonance Imaging 15, 763–770.CrossRefGoogle ScholarPubMed
Bridgett, DJ, Walker, ME (2006). Intellectual functioning in adults with ADHD: a meta-analytic examination of full scale IQ differences between adults with and without ADHD. Psychological Assessment 18, 1–14.CrossRefGoogle ScholarPubMed
Bullmore, E, Long, C, Suckling, J, Fadili, J, Calvert, G, Zelaya, F, Carpenter, TA, Brammer, M (2001). Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains. Human Brain Mapping 12, 61–78.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Bullmore, ET, Brammer, MJ, Rabe-Hesketh, S, Curtis, VA, Morris, RG, Williams, SC, Sharma, T, McGuire, PK (1999). Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Human Brain Mapping 7, 38–48.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Bunge, SA, Wright, SB (2007). Neurodevelopmental changes in working memory and cognitive control. Current Opinion in Neurobiology 17, 243–250.CrossRefGoogle ScholarPubMed
Bymaster, FP, Katner, JS, Nelson, DL, Hemrick-Luecke, SK, Threlkeld, PG, Heiligenstein, JH, Morin, SM, Gehlert, DR, Perry, KW (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699–711.CrossRefGoogle Scholar
Chamberlain, SR, Del Campo, N, Dowson, J, Muller, U, Clark, L, Robbins, TW, Sahakian, BJ (2007). Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biological Psychiatry 62, 977–984.CrossRefGoogle ScholarPubMed
Chamberlain, SR, Hampshire, A, Muller, U, Rubia, K, Del Campo, N, Craig, K, Regenthal, R, Suckling, J, Roiser, JP, Grant, JE, Bullmore, ET, Robbins, TW, Sahakian, BJ (2009). Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biological Psychiatry 65, 550–555.CrossRefGoogle ScholarPubMed
Chan, YP, Swanson, JM, Soldin, SS, Thiessen, JJ, Macleod, SM, Logan, W (1983). Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. Pediatrics 72, 56–59.Google ScholarPubMed
Christakou, A, Murphy, CM, Chantiluke, K, Cubillo, AI, Smith, AB, Giampietro, V, Daly, E, Ecker, C, Robertson, D; MRC AIMS consortium, Murphy, DG, Rubia, K (2013). Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (ADHD) and with autism. Molecular Psychiatry 18, 236–244.CrossRefGoogle ScholarPubMed
Conners, CK, Sitarenios, G, Parker, JDA, Epstein, JN (1998). Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology 26, 279–291.CrossRefGoogle ScholarPubMed
Crone, EA, Wendelken, C, Donohue, S, van Leijenhorst, L, Bunge, SA (2006). Neurocognitive development of the ability to manipulate information in working memory. Proceedings of the National Academy of Sciences USA 103, 9315–9320.CrossRefGoogle ScholarPubMed
Cubillo, A, Halari, R, Smith, A, Taylor, E, Rubia, K (2012 a). A review of fronto-striatal and frontocortical brain abnormalities in children and adults with attention deficit hyperactivity disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 48, 194–215.CrossRefGoogle ScholarPubMed
Cubillo, A, Smith, AB, Barrett, N, Giampietro, V, Brammer, MJ, Simmons, A, Rubia, K (2012 b). Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys. Cerebral Cortex. Published online 9 10 2012 . doi:10.1093/cercor/bhs296.Google ScholarPubMed
Dennis, M, Francis, DJ, Cirino, PT, Schachar, R, Barnes, MA, Fletcher, JM (2009). Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders. Journal of the International Neuropsychological Society 15, 331–343.CrossRefGoogle Scholar
Epstein, JN, Casey, BJ, Tonev, ST, Davidson, MC, Reiss, AL, Garrett, A, Hinshaw, SP, Greenhill, LL, Glover, G, Shafritz, KM, Vitolo, A, Kotler, LA, Jarrett, MA, Spicer, J (2007). ADHD- and medication-related brain activation effects in concordantly affected parent–child dyads with ADHD. Journal of Child Psychology and Psychiatry 48, 899–913.CrossRefGoogle ScholarPubMed
Evans, SH, Anastasio, EJ (1968). Misuse of analysis of covariance when treatment effect and covariate are confounded. Psychological Bulletin 69, 225–234.CrossRefGoogle ScholarPubMed
Flor-Henry, P (1986). Observations, reflections and speculations on the cerebral determinants of mood and on the bilaterally asymmetrical distributions of the major neurotransmitter systems. Acta Neurologica Scandinavica (Suppl.) 109, 75–89.CrossRefGoogle ScholarPubMed
Gallezot, JD, Weinzimmer, D, Nabulsi, N, Lin, SF, Fowles, K, Sandiego, C, McCarthy, TJ, Maguire, RP, Carson, RE, Ding, YS (2011). Evaluation of [11C]MRB for assessment of occupancy of norepinephrine transporters: studies with atomoxetine in non-human primates. Neuroimage 56, 268–279.CrossRefGoogle ScholarPubMed
Gamo, NJ, Wang, M, Arnsten, AF (2010). Methylphenidate and atomoxetine enhance prefrontal function through α 2-adrenergic and dopamine D1 receptors. Journal of the American Academy of Child and Adolescent Psychiatry 49, 1011–1023.CrossRefGoogle Scholar
Gau, SS, Shang, CY (2010). Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB). Journal of Child Psychology and Psychiatry 51, 838–849.CrossRefGoogle ScholarPubMed
Ginestet, CE, Simmons, A (2011). Statistical parametric network analysis of functional connectivity dynamics during a working memory task. Neuroimage 55, 688–704.CrossRefGoogle ScholarPubMed
Glick, SD, Ross, DA, Hough, LB (1982). Lateral asymmetry of neurotransmitters in human brain. Brain Research 234, 53–63.CrossRefGoogle ScholarPubMed
Goldberg, D, Murray, R (eds) (2002). Maudsley Handbook of Practical Psychiatry. Oxford University Press: Oxford.Google Scholar
Goldberg, MC, Mostofsky, SH, Cutting, LE, Mahone, EM, Astor, BC, Denckla, MB, Landa, RJ (2005). Subtle executive impairment in children with autism and children with ADHD. Journal of Autism and Developmental Disorders 35, 279–293.CrossRefGoogle ScholarPubMed
Goodman, R, Scott, S (1999). Comparing the Strengths and Difficulties Questionnaire and the Child Behavior Checklist: is small beautiful? Journal of Abnormal Child Psychology 27, 17–24.CrossRefGoogle ScholarPubMed
Graf, H, Abler, B, Freudenmann, R, Beschoner, P, Schaeffeler, E, Spitzer, M, Schwab, M, Gron, G (2011). Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biological Psychiatry 69, 890–897.CrossRefGoogle ScholarPubMed
Greenhill, LL, Swanson, JM, Vitiello, B, Davies, M, Clevenger, W, Wu, M, Arnold, LE, Abikoff, HB, Bukstein, OG, Conners, CK, Elliott, GR, Hechtman, L, Hinshaw, SP, Hoza, B, Jensen, PS, Kraemer, HC, March, JS, Newcorn, JH, Severe, JB, Wells, K, Wigal, T (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry 40, 180–187.CrossRefGoogle ScholarPubMed
Hannestad, J, Gallezot, JD, Planeta-Wilson, B, Lin, SF, Williams, WA, van Dyck, CH, Malison, RT, Carson, RE, Ding, YS (2010). Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo . Biological Psychiatry 68, 854–860.CrossRefGoogle ScholarPubMed
Hart, H, Radua, J, Mataix-Cols, D, Rubia, K (2012). Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD). Neuroscience and Biobehavioral Reviews 36, 2248–2256.CrossRefGoogle ScholarPubMed
Hart, H, Radua, J, Nakao, T, Mataix-Cols, D, Rubia, K (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 70, 185–198.CrossRefGoogle ScholarPubMed
Hazell, PL, Kohn, MR, Dickson, R, Walton, RJ, Granger, RE, van Wyk, GW (2010). Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. Journal of Attention Disorders 15, 674–683.CrossRefGoogle ScholarPubMed
Klein, C, Wendling, K, Huettner, P, Ruder, H, Peper, M (2006). Intra-subject variability in attention-deficit hyperactivity disorder. Biological Psychiatry 60, 1088–1097.CrossRefGoogle ScholarPubMed
Kobel, M, Bechtel, N, Weber, P, Specht, K, Klarhofer, M, Scheffler, K, Opwis, K, Penner, IK (2009). Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactivity disorder. European Journal of Paediatric Neurology 13, 516–523.CrossRefGoogle ScholarPubMed
Lancaster, JL, Rainey, LH, Summerlin, JL, Freitas, CS, Fox, PT, Evans, AC, Toga, AW, Mazziotta, JC (1997). Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Human Brain Mapping 5, 238–242.3.0.CO;2-4>CrossRefGoogle Scholar
Lancaster, JL, Woldorff, MG, Parsons, LM, Liotti, M, Freitas, CS, Rainey, L, Kochunov, PV, Nickerson, D, Mikiten, SA, Fox, PT (2000). Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping 10, 120–131.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Landau, SM, Lal, R, O'Neil, JP, Baker, S, Jagust, WJ (2009). Striatal dopamine and working memory. Cerebral Cortex 19, 445–454.CrossRefGoogle ScholarPubMed
Liddle, EB, Hollis, C, Batty, MJ, Groom, MJ, Totman, JJ, Liotti, M, Scerif, G, Liddle, PF (2010). Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. Journal of Child Psychology and Psychiatry 52, 761–771.CrossRefGoogle ScholarPubMed
Lijffijt, M, Kenemans, JL, ter Wal, A, Quik, EH, Kemner, C, Westenberg, H, Verbaten, MN, van Engeland, H (2006). Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder. European Psychiatry 21, 544–547.CrossRefGoogle ScholarPubMed
Marquand, AF, De Simoni, S, O'Daly, OG, Williams, SC, Mourao-Miranda, J, Mehta, MA (2011). Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology 36, 1237–1247.CrossRefGoogle ScholarPubMed
Martinussen, R, Hayden, J, Hogg-Johnson, S, Tannock, R (2005). A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 44, 377–384.CrossRefGoogle ScholarPubMed
Matthews, JN, Altman, DG (1996). Statistics notes. Interaction 2: compare effect sizes not P values. British Medical Journal 313, 808.CrossRefGoogle Scholar
Merikangas, KR, He, JP, Brody, D, Fisher, PW, Bourdon, K, Koretz, DS (2010). Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics 125, 75–81.CrossRefGoogle ScholarPubMed
Miller, G, Chapman, J (2001). Misunderstanding analysis of covariance. Journal of Abnormal Psychology 110, 40–48.CrossRefGoogle ScholarPubMed
Modi, N, Lindemulder, B, Gupta, S (2000). Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation. Journal of Clinical Pharmacology 40, 379–388.CrossRefGoogle ScholarPubMed
Montoya, A, Hervas, A, Cardo, E, Artigas, J, Mardomingo, MJ, Alda, JA, Gastaminza, X, Garcia-Polavieja, MJ, Gilaberte, I, Escobar, R (2009). Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naive children and adolescents with attention deficit/hyperactivity disorder. Current Medical Research and Opinion 25, 2745–2754.CrossRefGoogle ScholarPubMed
Nakao, T, Radua, J, Rubia, K, Mataix-Cols, D (2011). Gray matter volume abnormalities in ADHD and the effects of stimulant medication: voxel-based meta-analysis. American Journal of Psychiatry 168, 1154–1163.CrossRefGoogle ScholarPubMed
National Institute for Heath and Clinical Excellence (2008). Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults (http://www.nice.org.uk/CG72). Accessed 24 April 2012.Google Scholar
Owen, AM, McMillan, KM, Laird, AR, Bullmore, E (2005). N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Human Brain Mapping 25, 46–59.CrossRefGoogle ScholarPubMed
Pasini, A, Paloscia, C, Alessandrelli, R, Porfirio, MC, Curatolo, P (2007). Attention and executive functions profile in drug naive ADHD subtypes. Brain and Development 29, 400–408.CrossRefGoogle ScholarPubMed
Prehn-Kristensen, A, Krauel, K, Hinrichs, H, Fischer, J, Malecki, U, Schuetze, H, Wolff, S, Jansen, O, Duezel, E, Baving, L (2011). Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder. Brain Research 1388, 56–68.CrossRefGoogle Scholar
Rhodes, SM, Park, J, Seth, S, Coghill, DR (2011). A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder. Journal of Child Psychology and Psychiatry 53, 128–137.CrossRefGoogle ScholarPubMed
Rommelse, NN, Altink, ME, Oosterlaan, J, Buschgens, CJ, Buitelaar, J, Sergeant, JA (2008). Support for an independent familial segregation of executive and intelligence endophenotypes in ADHD families. Psychological Medicine 38, 1595–1606.CrossRefGoogle ScholarPubMed
Rubia, K (2011). ‘Cool’ inferior fronto-striatal dysfunction in attention-deficit hyperactivity disorder (ADHD) versus ‘hot’ ventromedial orbitofronto-limbic dysfunction in conduct disorder: a review. Biological Psychiatry 69, e69–e87.CrossRefGoogle Scholar
Rubia, K (2012). Functional brain imaging across development. European Child and Adolescent Psychiatry. Published online 24 06 2012 . doi:10.1007/s00787-012-0291-8.Google ScholarPubMed
Rubia, K, Halari, R, Christakou, A, Taylor, E (2009 a). Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 364, 1919–1931.CrossRefGoogle ScholarPubMed
Rubia, K, Halari, R, Cubillo, A, Mohammad, AM, Brammer, M, Taylor, E (2011 a). Methylphenidate normalises fronto-striatal underactivation during interference inhibition in medication-naive children with attention-deficit hyperactivity disorder. Neuropsychopharmacology 36, 1575–1586.CrossRefGoogle ScholarPubMed
Rubia, K, Halari, R, Cubillo, A, Mohammad, M, Taylor, E (2009 b). Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a Rewarded Continuous Performance Task. Neuropharmacology 57, 640–652.CrossRefGoogle ScholarPubMed
Rubia, K, Halari, R, Mohammad, AM, Taylor, E, Brammer, M (2011 b). Methylphenidate normalises fronto-cingulate underactivation during error processing in attention-deficit hyperactivity disorder. Biological Psychiatry 70, 255–262.CrossRefGoogle Scholar
Rutter, M, Bailey, A, Berument, S, LeCouteur, A, Lord, C, Pickles, A (eds) (2003). Social Communication Questionnaire (SCQ). Western Psychological Services: Los Angeles.Google Scholar
Sauer, J-M, Ponsler, GD, Mattiuz, EL, Long, AJ, Witcher, JW, Thomasson, HR, Desante, KA (2003). Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism. Drug Metabolism and Disposition 31, 98–107.CrossRefGoogle ScholarPubMed
Shafritz, KM, Marchione, KE, Gore, JC, Shaywitz, SE, Shaywitz, BA (2004). The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. American Journal of Psychiatry 161, 1990–1997.CrossRefGoogle ScholarPubMed
Sheridan, MA, Hinshaw, S, D'Esposito, M (2010). Stimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report. Journal of Attention Disorders 14, 69–78.CrossRefGoogle ScholarPubMed
Silk, T, Vance, A, Rinehart, N, Egan, G, O'Boyle, M, Bradshaw, JL, Cunnington, R (2005). Fronto-parietal activation in attention-deficit hyperactivity disorder, combined type: functional magnetic resonance imaging study. British Journal of Psychiatry 187, 282–283.CrossRefGoogle ScholarPubMed
Simmons, A, Moore, E, Williams, SC (1999). Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting. Magnetic Resonance in Medicine 41, 1274–1278.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Toplak, M, Jain, U, Rosemary, T (2008). Executive and motivational processes in adolescents with attention-deficit-hyperactivity disorder (ADHD). Behavioural and Brain Functions 1, 8.CrossRefGoogle Scholar
Tucker, DM, Williamson, PA (1984). Asymmetric neural control systems in human self-regulation. Psychological Review 91, 185–215.CrossRefGoogle ScholarPubMed
Vaidya, CJ, Austin, G, Kirkorian, G, Ridlehuber, HW, Desmond, JE, Glover, GH, Gabrieli, JDE (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proceedings of the National Academy of Sciences USA 95, 14494–14499.CrossRefGoogle ScholarPubMed
Valera, EM, Brown, A, Biederman, J, Faraone, SV, Makris, N, Monuteaux, MC, Whitfield-Gabrieli, S, Vitulano, M, Schiller, M, Seidman, LJ (2010). Sex differences in the functional neuroanatomy of working memory in adults with ADHD. American Journal of Psychiatry 167, 87–94.CrossRefGoogle ScholarPubMed
Vance, A, Silk, TJ, Casey, M, Rinehart, NJ, Bradshaw, JL, Bellgrove, MA, Cunnington, R (2007). Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study. Molecular Psychiatry 12, 826–832.CrossRefGoogle ScholarPubMed
Volkow, ND, Wang, GJ, Fowler, JS, Gatley, SJ, Logan, J, Ding, YS, Hitzemann, R, Pappas, N (1998). Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry 155, 1325–1331.CrossRefGoogle ScholarPubMed
Wechsler, D (1999). Wechsler Abbreviated Scale of Intelligence. Psychological Corp.: San Antonio, TX.Google Scholar
Wechsler, D (2004). Wechsler Intelligence Scale for Children, 4th edn. Psychological Corp.: London, UK.Google Scholar
Willcutt, EG, Doyle, AE, Nigg, JT, Faraone, SV, Pennington, BF (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biological Psychiatry 57, 1336–1346.CrossRefGoogle ScholarPubMed
Witcher, JW, Long, A, Smith, B, Sauer, JM, Heilgenstein, J, Wilens, T, Spencer, T, Biederman, J (2003). Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 13, 53–63.CrossRefGoogle ScholarPubMed
Wong, CG, Stevens, MC (2012). The effects of stimulant medication on working memory functional connectivity in attention-deficit/hyperactivity disorder. Biological Psychiatry 71, 458–466.CrossRefGoogle ScholarPubMed
Supplementary material: File

Cubillo Supplementary Material

Cubillo Supplementary Material

Download Cubillo Supplementary Material(File)
File 7 MB